Tema Neuroscience and Mental Health ETF (MNTL) Holdings $22.10 -0.13 (-0.60%) Closing price 05/23/2025 02:47 PM EasternExtended Trading$22.10 0.00 (0.00%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 48 MNTL HoldingsRankCompanyCurrent PriceWeightShares Held1VRTXVertex Pharmaceuticals$436.00+0.5%10.23%2,2982REGNRegeneron Pharmaceuticals$588.34-1.4%7.86%1,2843ALNYAlnylam Pharmaceuticals$289.96+0.3%5.76%1,9824ARGXargenx$587.61+1.1%5.13%8905TEVATeva Pharmaceutical Industries$16.95+0.0%4.82%28,8616NBIXNeurocrine Biosciences$120.18+0.9%4.78%3,9047CRNXCrinetics Pharmaceuticals$29.76-1.2%4.08%13,0668LLYEli Lilly and Company$713.99-0.2%4.07%5479BIIBBiogen$125.81-0.4%3.25%2,50110SYKStryker$377.01-0.3%3.10%798 Get the Latest News and Ratings for MNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. 11IONSIonis Pharmaceuticals$32.98-0.8%2.86%8,31812CPRXCatalyst Pharmaceuticals$24.49+1.6%2.79%11,35213MDTMedtronic$80.70-0.3%2.56%2,97614AXSMAxsome Therapeutics$105.07+0.7%2.51%2,32715ACADACADIA Pharmaceuticals$21.98+2.0%2.29%10,59616First American Treasury Obligations FundN/A2.20%220,99017DNLIDenali Therapeutics$13.42-1.8%2.16%15,17418UCB SAN/A2.16%1,19319DXCMDexCom$84.51-0.4%1.94%2,23120XENEXenon Pharmaceuticals$29.75-2.4%1.91%6,11121ALKSAlkermes$29.35-2.3%1.87%5,94022JAZZJazz Pharmaceuticals$108.07+0.2%1.85%1,67223PENPenumbra$268.72+0.7%1.73%61724RNAAvidity Biosciences$30.58-0.7%1.70%5,39225OPCHOption Care Health$31.41-1.9%1.64%4,97526SRRKScholar Rock$30.00-1.5%1.52%4,83627PTCTPTC Therapeutics$45.93+0.9%1.47%3,12428Siemens Healthineers AGN/A1.38%2,49529Sysmex CorporationN/A1.02%6,10830Orion OyjN/A0.93%1,44031IMVTImmunovant$14.46-0.7%0.88%5,86632TALKTalkspace$2.82+2.2%0.83%27,83433SRPTSarepta Therapeutics$37.90-2.3%0.77%1,94334DAWNDay One Biopharmaceuticals$6.270.74%11,30535NTLAIntellia Therapeutics$9.16-3.2%0.74%7,67736ACHCAcadia Healthcare$22.53-1.9%0.65%2,59637BHVNBiohaven$15.67+1.5%0.62%3,83138DYNDyne Therapeutics$11.69-1.8%0.58%4,71739Eisai Co., Ltd.N/A0.54%2,03640VYGRVoyager Therapeutics$2.92-2.3%0.51%14,960Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos41PRTAProthena$6.58+0.5%0.46%6,35142PRAXPraxis Precision Medicines$37.55-2.0%0.42%1,05543SLDBSolid Biosciences$2.81-2.8%0.25%8,64944RAPPRapport Therapeutics$10.82-2.7%0.15%1,49945ARVNArvinas$6.51+0.6%0.14%2,07446EURON/A0.12%10,24447JAPANESE YENN/A0.03%425,87448DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.02%22,920,447 Geographic ExposureUnited States83.3%Ireland6.6%Belgium2.2%Canada1.9%Japan1.6%Germany1.4%Finland1.0%Virgin Islands, British0.6%Currency ExposureUSD93.7%EUR4.7%JPY1.7%Sector ExposureHealth Care96.7%Industry ExposureBiotechnology80.1%Health Care Equipment & Supplies11.6%Health Care Providers & Services3.0%Pharmaceuticals2.0%SubIndustry ExposureBiotechnology72.2%Health Care Equipment10.6%Pharmaceuticals4.5%Health Care Services2.4%Life Sciences Tools & Services1.0%Health Care Facilities0.6%Coupon Exposure4-62.3%Maturity Exposure15-202.3% Related Companies and Tools Related Companies FIVY Holdings GXDW Holdings TMET Holdings DYNI Holdings AQWA Holdings KROP Holdings NIKL Holdings SPCX Holdings GXTG Holdings ESMV Holdings This page (NASDAQ:MNTL) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.